LAURUSLABS.NS Profit & Loss
Laurus Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:35
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹60.41 Bn | ₹50.41 Bn | ₹55.54 Bn | ₹68.13 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.06 Bn | ₹0.26 Bn | ₹0.75 Bn | ₹0.55 Bn | OtherIncome |
| Total Income | ₹60.47 Bn | ₹50.67 Bn | ₹56.29 Bn | ₹68.68 Bn | Income |
| Cost of Materials Consumed | ₹25.97 Bn | ₹24.22 Bn | ₹24.29 Bn | ₹27.94 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹1.56 Bn | ₹1.11 Bn | ₹1.05 Bn | ₹1.73 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹0.22 Bn | ₹-1.01 Bn | ₹-0.56 Bn | ₹-2.71 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹5.81 Bn | ₹6.40 Bn | ₹7.20 Bn | ₹8.95 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹1.65 Bn | ₹1.83 Bn | ₹2.16 Bn | ₹1.71 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹3.24 Bn | ₹3.85 Bn | ₹4.30 Bn | ₹4.80 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹10.93 Bn | ₹11.91 Bn | ₹13.01 Bn | ₹14.44 Bn | OtherExpenses |
| Total Expenses | ₹49.38 Bn | ₹48.31 Bn | ₹51.45 Bn | ₹56.86 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹11.09 Bn | ₹2.36 Bn | ₹4.84 Bn | ₹11.82 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹11.09 Bn | ₹2.36 Bn | ₹4.84 Bn | ₹11.82 Bn | ProfitBeforeTax |
| Tax Expense | ₹3.12 Bn | ₹0.68 Bn | ₹1.30 Bn | ₹2.92 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹7.93 Bn | ₹1.62 Bn | ₹3.58 Bn | ₹8.90 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹7.90 Bn | ₹1.61 Bn | ₹3.58 Bn | ₹8.89 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹14.69 | ₹2.98 | ₹6.65 | ₹16.47 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹14.64 | ₹2.97 | ₹6.64 | ₹16.45 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from LAURUSLABS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).